1. Evstratov, A. V. (2018). The main trends and prospects for developing the pharmaceutical market in the Russian Federation. Volgograd State Technical University.
2. Government of the Russian Federation. (2020). Decree “On peculiarities of circulation of medicines for medical use, which are intended for use in conditions of threat of emergence, emergence, and liquidation of an emergency situation and for organization of medical assistance to persons affected by emergencies, prevention of emergency situations, prevention and treatment of diseases that are dangerous to the environment, and diseases and injuries suffered as a result of adverse chemical, biological, and radiation factors” (April 3, 2020 No. 441). Retrieved from https://www.garant.ru/products/ipo/prime/doc/73750814/ (Accessed 8 November 2022).
3. Izmaylov, A. M, Evstratov, A. V., & Heidelberg, E. (2022). Big Data applications in the pharmaceutical industry. In S. I. Ashmarina, & V. V. Mantulenko (Eds.), Digital technologies in the new socio-economic reality (pp. 67–72). Springer. https://doi.org/10.1007/978-3-030-83175-2_10.
4. Ministry of Industry and Trade of the Russian Federation. (2009). Order “On approval of the Strategy for the development of the pharmaceutical industry of the Russian Federation for the period up to 2020” (October 23, 2009 No. 965). Retrieved from https://base.garant.ru/4189282/ (Accessed 8 November 2022).
5. Narkevich, I. A., & Trofimova, E. O. (2011). New generation of manpower for pharmaceutical industries. Remedium, 6, 68–73. Retrieved from https://cyberleninka.ru/article/n/perspektivy-obespecheniya-farmatsevticheskoy-promyshlennosti-kadrami-novogo-tipa (Accessed 15 October 2022).